Micro
Emerging
Active
West Pharmaceutical CEO 出局
新的叙述，覆盖范围有限 — 仍在形成中。
评分
0.2
动能
▲ 0.0
文章
4
来源
2
热门股
| 股票代码 | 板块 | 变动 |
|---|---|---|
| — | +4.8% |
情绪时间线
事件时间线
假设
Pending
到期: 2026年7月25日
West Pharmaceutical's Q3 2024 revenue guidance will be maintained or increased (no downward revision) despite CEO transition, with management affirming full-year 2024 outlook, demonstrating operational stability.
Pending
到期: 2026年6月25日
If West Pharmaceutical announces an internal successor within 60 days of CEO exit announcement, WST stock will recover and trade at or above pre-announcement levels by day 90, indicating market confidence in continuity.
Pending
到期: 2026年4月6日
West Pharmaceutical Services (WST) stock will experience a negative price reaction of 3-5% within 5 trading days following the CEO exit announcement due to succession uncertainty and potential disruption to strategic initiatives.
热门股
| 股票代码 | 板块 | 变动 |
|---|---|---|
| — | +4.8% |
时间线
首次发现三月 27, 2026
最后更新三月 27, 2026